RhumbLine Advisers’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-22,417
| Closed | -$206K | – | 3043 |
|
|
2017
Q1 | $206K | Buy |
22,417
+2,179
| +11% | +$20K | ﹤0.01% | 2646 |
|
|
2016
Q4 | $156K | Buy |
20,238
+1,718
| +9% | +$13.2K | ﹤0.01% | 2733 |
|
|
2016
Q3 | $212K | Buy |
18,520
+1,625
| +10% | +$18.6K | ﹤0.01% | 2653 |
|
|
2016
Q2 | $208K | Buy |
16,895
+425
| +3% | +$5.23K | ﹤0.01% | 2723 |
|
|
2016
Q1 | $167K | Buy |
16,470
+165
| +1% | +$1.67K | ﹤0.01% | 2792 |
|
|
2015
Q4 | $368K | Buy |
16,305
+1,435
| +10% | +$32.4K | ﹤0.01% | 2450 |
|
|
2015
Q3 | $247K | Buy |
14,870
+575
| +4% | +$9.55K | ﹤0.01% | 2667 |
|
|
2015
Q2 | $322K | Buy |
14,295
+2,465
| +21% | +$55.5K | ﹤0.01% | 2613 |
|
|
2015
Q1 | $305K | Buy |
11,830
+1,600
| +16% | +$41.3K | ﹤0.01% | 2603 |
|
|
2014
Q4 | $223K | Buy |
+10,230
| New | +$223K | ﹤0.01% | 2747 |
|
|
2014
Q3 | – | Sell |
-9,930
| Closed | -$231K | – | 3032 |
|
|
2014
Q2 | $231K | Buy |
+9,930
| New | +$231K | ﹤0.01% | 2751 |
|